Literature DB >> 24380399

Development of a novel efficient method to construct an adenovirus library displaying random peptides on the fiber knob.

Yuki Yamamoto1, Naoko Goto, Kazuki Miura, Kenta Narumi, Shumpei Ohnami, Hiroaki Uchida, Yoshiaki Miura, Masato Yamamoto, Kazunori Aoki.   

Abstract

Redirection of adenovirus vectors by engineering the capsid-coding region has shown limited success because proper targeting ligands are generally unknown. To overcome this limitation, we constructed an adenovirus library displaying random peptides on the fiber knob, and its screening led to successful selections of several particular targeted vectors. In the previous library construction method, the full length of an adenoviral genome was generated by a Cre-lox mediated in vitro recombination between a fiber-modified plasmid library and the enzyme-digested adenoviral DNA/terminal protein complex (DNA-TPC) before transfection to the producer cells. In this system, the procedures were complicated and time-consuming, and approximately 30% of the vectors in the library were defective with no displaying peptide. These may hinder further extensive exploration of cancer-targeting vectors. To resolve these problems, in this study, we developed a novel method with the transfection of a fiber-modified plasmid library and a fiberless adenoviral DNA-TPC in Cre-expressing 293 cells. The use of in-cell Cre recombination and fiberless adenovirus greatly simplified the library-making steps. The fiberless adenovirus was useful in suppressing the expansion of unnecessary adenovirus vectors. In addition, the complexity of the library was more than a 10(4) level in one well in a 6-well dish, which was 10-fold higher than that of the original method. The results demonstrated that this novel method is useful in producing a high quality live adenovirus library, which could facilitate the development of targeted adenovirus vectors for a variety of applications in medicine.

Entities:  

Keywords:  Cre recombination; adenovirus; fiberless; library; targeting vector

Mesh:

Substances:

Year:  2014        PMID: 24380399      PMCID: PMC4110195          DOI: 10.1021/mp4005854

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  23 in total

1.  In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors.

Authors:  Stuart A Nicklin; Steve J White; Campbell G Nicol; Dan J Von Seggern; Andrew H Baker
Journal:  J Gene Med       Date:  2004-03       Impact factor: 4.565

2.  Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.

Authors:  V Legrand; D Spehner; Y Schlesinger; N Settelen; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

3.  Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.

Authors:  S A Nicklin; D J Von Seggern; L M Work; D C Pek; A F Dominiczak; G R Nemerow; A H Baker
Journal:  Mol Ther       Date:  2001-12       Impact factor: 11.454

4.  HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.

Authors:  R P Tomko; R Xu; L Philipson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.

Authors:  Oliver J Müller; Felix Kaul; Matthew D Weitzman; Renata Pasqualini; Wadih Arap; Jürgen A Kleinschmidt; Martin Trepel
Journal:  Nat Biotechnol       Date:  2003-08-03       Impact factor: 54.908

6.  Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma.

Authors:  Y Yoshida; A Sadata; W Zhang; K Saito; N Shinoura; H Hamada
Journal:  Hum Gene Ther       Date:  1998-11-20       Impact factor: 5.695

7.  Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.

Authors:  T Nishimoto; K Yoshida; Y Miura; A Kobayashi; H Hara; S Ohnami; K Kurisu; T Yoshida; K Aoki
Journal:  Gene Ther       Date:  2009-02-19       Impact factor: 5.250

8.  Use of in vivo phage display to engineer novel adenoviruses for targeted delivery to the cardiac vasculature.

Authors:  Campbell G Nicol; Laura Denby; Oscar Lopez-Franco; Rachel Masson; Crawford A Halliday; Stuart A Nicklin; Angelika Kritz; Lorraine M Work; Andrew H Baker
Journal:  FEBS Lett       Date:  2009-05-28       Impact factor: 4.124

9.  An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Authors:  I Dmitriev; V Krasnykh; C R Miller; M Wang; E Kashentseva; G Mikheeva; N Belousova; D T Curiel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

View more
  5 in total

Review 1.  Retargeting adenoviruses for therapeutic applications and vaccines.

Authors:  Michael A Barry; Jeffrey D Rubin; Shao-Chia Lu
Journal:  FEBS Lett       Date:  2020-02-03       Impact factor: 4.124

2.  Retargeted and detargeted adenovirus for gene delivery to the muscle.

Authors:  Tien V Nguyen; Stephanie S Anguiano-Zarate; William E Matchett; Mary E Barry; Michael A Barry
Journal:  Virology       Date:  2017-11-22       Impact factor: 3.616

Review 3.  Recent advances in genetic modification of adenovirus vectors for cancer treatment.

Authors:  Yuki Yamamoto; Masaki Nagasato; Teruhiko Yoshida; Kazunori Aoki
Journal:  Cancer Sci       Date:  2017-05-07       Impact factor: 6.716

4.  Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.

Authors:  Yuki Yamamoto; Masaki Nagasato; Yosei Rin; Marina Henmi; Yoshinori Ino; Shinichi Yachida; Rieko Ohki; Nobuyoshi Hiraoka; Masatoshi Tagawa; Kazunori Aoki
Journal:  Cancer Med       Date:  2017-09-21       Impact factor: 4.452

Review 5.  Role of Gene Therapy in Pancreatic Cancer-A Review.

Authors:  Mizuho Sato-Dahlman; Keith Wirth; Masato Yamamoto
Journal:  Cancers (Basel)       Date:  2018-04-03       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.